Global Medical Foods Market- By Application, By Type, By Sales Channel -Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Description

According to SPER Market Research, the Global Medical Foods Market is estimated to reach USD 34.32 billion by 2030 with a CAGR of 5.5%.

The medical foods market consists of sales of medical foods by entities (organizations, sole traders, and partnerships) that refer to foods, which are formulated to be administered or consumed under the presence of a physician, and it is intended to provide specific dietary management of a disease for which nutritional requirements are established by medical evaluation. Medical food pills are specially formulated to meet the nutritional requirements of patients with various medical conditions such as digression, ADHD, and others. They are used in the treatment of Alzheimer's disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, and others. As people get old, their dependency on certain nutritional foods increases especially medical foods to manage their health from chronic and age-related diseases.

The companies operating in the medical foods sector are developing innovative products with greater efficacy to cater to the demand from customers with specific niche diseases such as metabolic disorders, ADHD, and others.

Major players in the medical foods market are: Nestle, Fresenius Se & Co., Danone, Primus Pharmaceuticals Inc., Abbott Laboratories, Metagenics Inc., Targeted Medical Pharma Inc.

Impact of COVID-19 on the Global Medical Foods Market:

The report delivers insights on COVID-19 considering the changes in consumer behaviour and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments.

Scope of the report:

Report Metric Details

Market size available for years: 2019-2030
Base year considered: 2021
Forecast period: 2022-2030

Segments covered: By Application, By Type, By Sales Channel, By Region

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered: Abbott Laboratories, Cerecin Inc., Danone, Fresenius SE & Co., Meiji Holdings and Co. Ltd., Metagenics Inc., Nestle, Primus Pharmaceuticals Inc., Reckitt Benckiser Group, Targeted Medical Pharma Inc.

Global Medical Foods Market, By Application:

Based on the application, Global Medical Foods Market is segmented as; Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Others.

Global Medical Foods Market, By Type:

Based on the type, Global Medical Foods Market is segmented as; Pills, Powder, Others.

Global Medical Foods Market, By Sales Channel:

Based on the sales channel, Global Medical Foods Market is segmented as; Retail Sales, Online Sales, Institutional Sales.

Global Medical Foods Market, By Region:

North America was the largest region in the medical foods market. Asia-Pacific is expected to be the fastest-growing region in the global medical foods market during the forecast period.

Product Code: HLCA2206

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source
- 2.1.1. Secondary data
- 2.1.2. Primary data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2 Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Medical Foods Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL analysis
- 5.2.1. Political landscape
- 5.2.2. Economic landscape
- 5.2.3. Social landscape
- 5.2.4. Technological landscape
- 5.2.5. Environmental landscape
- 5.2.6. Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of Buyers

5.3.3.Threat of Substitute

5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat map analysis

6. Global Medical Foods Market, By Application, 2019-2030 (USD Million)

6.1. Alzheimer's Disease
6.2. Diabetic Neuropathy
6.3. Nutritional Deficiency
6.4. ADHD
6.5. Others

7. Global Medical Foods Market, By Type, 2019-2030 (USD Million)

7.1. Pills
7.2. Powder
7.3. Others

8. Global Medical Foods Market, By Sales Channel, 2019-2030 (USD Million)

8.1. Retail Sales
8.2. Online Sales
8.3. Institutional Sales

9. Global Medical Foods Market, By Region, 2019-2030 (USD Million)

9.1. North America
- 9.1.1. United States
- 9.1.2. Canada
- 9.1.3. Mexico
9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia-Pacific
9.4. South America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of South America
9.5. Middle East & Africa
- 9.5.1. Kingdom of Saudi Arabia
- 9.5.2. United Arab Emirates
- 9.5.3. Rest of Middle East & Africa

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
10.2. Cerecin Inc.
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
10.3. Danone
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
10.4. Fresenius SE & Co.
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
10.5. Meiji Holdings & Co. Ltd.
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
10.6. Metagenics Inc.
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
10.7. Nestle
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
10.8. Primus Pharmaceuticals Inc.
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
10.9. Reckitt Benckiser Group
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
10.10. Targeted Medical Pharma Inc.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments